Compare GRFS & BOOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GRFS | BOOT |
|---|---|---|
| Founded | 1940 | 1978 |
| Country | Spain | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Clothing/Shoe/Accessory Stores |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.2B | 5.3B |
| IPO Year | 2006 | 2014 |
| Metric | GRFS | BOOT |
|---|---|---|
| Price | $9.48 | $182.02 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 2 | 13 |
| Target Price | $10.15 | ★ $212.42 |
| AVG Volume (30 Days) | 467.0K | ★ 734.3K |
| Earning Date | 07-28-2022 | 02-04-2026 |
| Dividend Yield | ★ 1.54% | N/A |
| EPS Growth | N/A | ★ 36.30 |
| EPS | 0.64 | ★ 6.78 |
| Revenue | ★ $8,821,017,248.00 | $2,071,382,000.00 |
| Revenue This Year | $5.36 | $19.46 |
| Revenue Next Year | $5.15 | $13.49 |
| P/E Ratio | ★ $17.84 | $26.31 |
| Revenue Growth | 7.31 | ★ 17.82 |
| 52 Week Low | $6.19 | $86.17 |
| 52 Week High | $11.14 | $210.25 |
| Indicator | GRFS | BOOT |
|---|---|---|
| Relative Strength Index (RSI) | 57.30 | 45.87 |
| Support Level | $9.12 | $171.46 |
| Resistance Level | $9.30 | $202.26 |
| Average True Range (ATR) | 0.21 | 7.43 |
| MACD | 0.02 | -1.24 |
| Stochastic Oscillator | 91.74 | 33.58 |
Grifols SA one of is global specialty plasma therapeutics companies developing, manufacturing and distributing a broad range of biological medicines based on plasma derived proteins. Plasma derivatives are proteins found in human plasma, which once isolated and purified, have therapeutic value. These protein-based therapies extend and enhance the lives of individuals who suffer from chronic and acute, often life-threatening, conditions, including primary and secondary immunological deficiencies, Chronic Inflammatory Demyelinating Polyneuropathy, immune-mediated ITP. Products and services are used to diagnose and treat patients with hemophilia, immune deficiencies, infectious diseases and a range of other medical conditions. Majority of revenue is from USA.
Boot Barn Holdings Inc operates specialty retail stores. The company sells western and work-related footwear, apparel, and accessories in the United States. It is a single operating segment, which includes net sales generated from its retail stores and e-commerce websites.